Prospective comparison of the detection rates of 68Ga-DOTA-TATE and 11C-choline PET/CT in PCa patients with BCR was used to evaluate the targeted therapy and diagnosis of SSTR expression. The gene discussed is BCR; the disease is posterior cortical atrophy.